JUL 23, 2015
Academy Succeeds in Adding Members of U.S. Senate to Campaign to Ensure Avastin Access
The Academy’s latest step in campaigning to ensuring continued access to repackaged drugs was taken last week when members of the U.S. Senate sent a letter to the Food and Drug Administration urging continued access to repackaged biologics such as bevacizumab, also known as Avastin.